by Q1Web Admin | Apr 27, 2017 | Pharmaceutical
Measuring the Impact of Patient Advocacy How Wendy Erler of WAVE Life Sciences Defines Success How Wendy Erler of WAVE Life Sciences Defines Success Patient advocacy is a complex field that relies on stakeholder balance and representation. To adequately address the...
by Q1Web Admin | Apr 26, 2017 | Blog, Pharmaceutical
Producing MES Success It's Easier Than You Think Producing MES Success When considering implementing an automated pharmaceutical manufacturing solution, planning is crucial to shorter ROI periods and long-term success. Benchmarking this success means developing...
by Q1Web Admin | Apr 21, 2017 | Pharmaceutical
MES 101: Implementation and Beyond MES 101: Implementation and Beyond The road to MES production starts with an initial scope and lifecycle overview. One pressing concern for pharmaceutical manufacturers is the transition to automated production, and how an MES...
by Q1Web Admin | Apr 10, 2017 | Pharmaceutical
New Age Regulatory Operations: How the eCTD has Changed Submission Teams How the eCTD has Changed Submission Teams In May of this year, regulatory operations leaders will finally begin preparing therapy submissions under one standardized format. The eCTD’s...
by Q1Web Admin | Apr 5, 2017 | Blog, Pharmaceutical
MES 101: Implementation and Beyond MES 101: Implementation and Beyond The road to MES production starts with an initial scope and lifecycle overview. One pressing concern for pharmaceutical manufacturers is the transition to automated production, and how an MES...
by Q1Web Admin | Mar 29, 2017 | Blog, Pharmaceutical
Digital Medical Affairs How One Company is Redefining Scientific Exchange How One Company is Redefining Scientific Exchange Scientific exchange is an integral part of the pre-launch phase for medical affairs. Traditionally, this information is deployed to...